Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy × abiraterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27 Neoplasm Metastasis 3 Metastatic Castration-Resistant Prostate Cancer 2 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration Resistant Prostate Cancer 1 Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy 1 Advanced Prostate Carcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01780220 2022-05-19

CARLHA

UNICANCER

Phase 1/2 Completed

Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡